×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| PARNAX LAB LTD. | NA | NA | NA | NA | 144.0 | 13.4 |
| AURO LABORATORIES LTD. | NA | NA | NA | NA | 144 | 208.0 |
| TYCHE INDUSTRIES LTD. | NA | NA | NA | NA | 140 | 11.5 |
Parnax Lab Limited, with Security Code 506128, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.2 | 2.4 | 1.1 | 1.8 | 2.8 | 1.7 | 3.7 | 1.5 | 1.0 | 0.8 |
| Expenses | 1.0 | 1.5 | 1.1 | 1.1 | 1.5 | 1.5 | 2.4 | 1.3 | 0.9 | 1.1 |
| Operating Profit | 0.1 | 0.9 | 0.0 | 0.7 | 1.2 | 0.2 | 1.3 | 0.2 | 0.1 | -0.2 |
| OPM % | 10.5% | 37.66% | 1.86% | 38.21% | 44.47% | 9.31% | 34.23% | 12.96% | 6.59% | -28.91% |
| Other Income | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 |
| Interest | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit before tax | 0.2 | 1.0 | 0.1 | 0.8 | 1.3 | 0.2 | 1.4 | 0.4 | 0.2 | -0.1 |
| Tax % | -37.7% | -26.7% | -25.8% | -24.4% | -25.6% | -28.1% | -25.2% | -25.2% | -23.3% | 0% |
| Net Profit | 0.1 | 0.7 | 0.1 | 0.6 | 1.0 | 0.2 | 1.1 | 0.3 | 0.2 | -0.1 |
| EPS in Rs | 0.1 | 0.66 | 0.06 | 0.52 | 0.86 | 0.15 | 0.91 | 0.24 | 0.14 | 0 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 46.8 | 40.9 | 48.7 | 42.6 | 51.0 | 46.4 | 50.1 | 48.4 | 40.2 | 49.0 |
| Expenses | 39.4 | 36.2 | 42.2 | 37.3 | 45.0 | 40.6 | 41.5 | 41.1 | 35.9 | 42.4 |
| Operating Profit | 7.4 | 4.7 | 6.5 | 5.3 | 6.0 | 5.8 | 8.6 | 7.2 | 4.3 | 6.6 |
| OPM % | 15.75% | 11.58% | 13.33% | 12.4% | 11.71% | 12.5% | 17.19% | 14.98% | 10.63% | 13.55% |
| Other Income | 0.1 | 0.3 | 0.2 | 0.2 | 0.1 | 0.2 | 0.1 | 1.0 | 0.2 | 0.4 |
| Interest | 1.3 | 1.2 | 1.2 | 1.4 | 1.4 | 1.4 | 1.5 | 1.4 | 1.2 | 1.3 |
| Depreciation | 1.7 | 1.6 | 1.6 | 1.7 | 1.8 | 1.8 | 1.8 | 1.9 | 1.8 | 1.8 |
| Profit before tax | 4.4 | 2.2 | 4.0 | 2.3 | 2.9 | 2.8 | 5.4 | 4.9 | 1.4 | 4.0 |
| Tax % | -28.6% | -44.1% | -16.4% | -20% | -25.9% | -19.5% | -26.2% | -29.9% | -16.2% | -25.3% |
| Net Profit | 3.2 | 1.4 | 3.3 | 1.9 | 2.2 | 2.2 | 4.0 | 3.4 | 1.2 | 2.9 |
| EPS in Rs | 2.96 | 1.3 | 2.9 | 1.63 | 1.9 | 1.95 | 3.47 | 2.97 | 1.06 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | 3% |
| 3 Years: | 46% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 33% |
| 3 Years: | 53% |
| TTM: | -31% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 39% |
| 3 Years: | -8% |
| 1 Year: | -13% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 12% |
| 3 Years: | 28% |
| TTM: | 1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 24% |
| 3 Years: | 203% |
| TTM: | 23% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 39% |
| 3 Years: | -8% |
| 1 Year: | -13% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|